Literature DB >> 17032923

Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo.

Ralph Tiedt1, Tibor Schomber, Hui Hao-Shen, Radek C Skoda.   

Abstract

To generate transgenic mice that express Cre-recombinase exclusively in the megakaryocytic lineage, we modified a mouse bacterial artificial chromosome (BAC) clone by homologous recombination and replaced the first exon of the platelet factor 4 (Pf4), also called CXCL4, with a codon-improved Cre cDNA. Several strains expressing the transgene were obtained and one strain, Q3, was studied in detail. Crossing Q3 mice with the ROSA26-lacZ reporter strain showed that Cre-recombinase activity was confined to megakaryocytes. These results were further verified by crossing the Q3 mice with a strain containing loxP-flanked integrin beta1. Excision of this conditional allele in megakaryocytes was complete at the DNA level, and platelets were virtually devoid of the integrin beta1 protein. The Pf4-Cre transgenic strain will be a valuable tool to study megakaryopoiesis, platelet formation, and platelet function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17032923     DOI: 10.1182/blood-2006-04-020362

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  197 in total

1.  A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.

Authors:  Hui Huang; Andrew J Woo; Zachary Waldon; Yocheved Schindler; Tyler B Moran; Helen H Zhu; Gen-Sheng Feng; Hanno Steen; Alan B Cantor
Journal:  Genes Dev       Date:  2012-07-03       Impact factor: 11.361

2.  Talin-dependent integrin activation is required for fibrin clot retraction by platelets.

Authors:  Jacob R Haling; Susan J Monkley; David R Critchley; Brian G Petrich
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

3.  Off-targets effects underlie the inhibitory effect of FAK inhibitors on platelet activation: studies using Fak-deficient mice.

Authors:  M E Roh; M Cosgrove; K Gorski; I S Hitchcock
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

4.  The heterotrimeric G protein Gβ1 interacts with the catalytic subunit of protein phosphatase 1 and modulates G protein-coupled receptor signaling in platelets.

Authors:  Subhashree Pradhan; Tanvir Khatlani; Angus C Nairn; K Vinod Vijayan
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

5.  Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice.

Authors:  Clare L Abram; Gray L Roberge; Yongmei Hu; Clifford A Lowell
Journal:  J Immunol Methods       Date:  2014-05-22       Impact factor: 2.303

6.  Fluorescent labeling of endogenous platelets for intravital microscopy: Effects on platelet function.

Authors:  Qi Da; Paul J Derry; Fong W Lam; Rolando E Rumbaut
Journal:  Microcirculation       Date:  2018-05-30       Impact factor: 2.628

Review 7.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

8.  Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding.

Authors:  Shujian Wei; Huan Wang; Guoying Zhang; Ying Lu; Xiaofei An; Shumei Ren; Yunmei Wang; Yuguo Chen; James G White; Chunxiang Zhang; Daniel I Simon; Chaodong Wu; Zhenyu Li; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

9.  JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.

Authors:  S Leah Etheridge; Michelle E Roh; Megan E Cosgrove; Veena Sangkhae; Norma E Fox; Junmei Chen; José A López; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

10.  IκB kinase phosphorylation of SNAP-23 controls platelet secretion.

Authors:  Zubair A Karim; Jinchao Zhang; Meenakshi Banerjee; Michael C Chicka; Rania Al Hawas; Tara R Hamilton; Paul A Roche; Sidney W Whiteheart
Journal:  Blood       Date:  2013-04-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.